Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Mendelman

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Pediatrics|January 1, 1992
Bacteriology of acute otitis media: a new perspectiveM A Del Beccaro, P M Mendelman, A F Inglis, et al.
Pediatric Emergency Care|August 1, 1995
Cerebrospinal fluid analysis in children with seizuresL G Rider, P B Thapa, M A Del Beccaro, et al.
Papua and New Guinea Medical Journal|August 10, 2000
Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean childrenD Lehmann, M Kakazo, S Yarsley, et al.
JAMA|July 20, 1999
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trialK L Nichol, P M Mendelman, K P Mallon, et al.
Infection and Immunity|April 1, 1989
Genetic diversity of penicillin G-resistant Neisseria meningitidis from SpainP M Mendelman, D A Caugant, G Kalaitzoglou, et al.
The Journal of Infectious Diseases|November 1, 1990
Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteinsP M Mendelman, D O Chaffin, L R Krilov, et al.
Pediatrics|August 3, 2001
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy childrenB R Luce, K M Zangwill, C S Palmer, et al.
The New England Journal of Medicine|May 15, 1998
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in childrenR B Belshe, P M Mendelman, J Treanor, et al.
Vaccine|April 1, 1997
Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIBP M Mendelman, L Feeley, S Bird, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Pediatrics|January 1, 1992
Bacteriology of acute otitis media: a new perspectiveM A Del Beccaro, P M Mendelman, A F Inglis, et al.
Pediatric Emergency Care|August 1, 1995
Cerebrospinal fluid analysis in children with seizuresL G Rider, P B Thapa, M A Del Beccaro, et al.
Papua and New Guinea Medical Journal|August 10, 2000
Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean childrenD Lehmann, M Kakazo, S Yarsley, et al.
JAMA|July 20, 1999
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trialK L Nichol, P M Mendelman, K P Mallon, et al.
Infection and Immunity|April 1, 1989
Genetic diversity of penicillin G-resistant Neisseria meningitidis from SpainP M Mendelman, D A Caugant, G Kalaitzoglou, et al.
The Journal of Infectious Diseases|November 1, 1990
Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteinsP M Mendelman, D O Chaffin, L R Krilov, et al.
Pediatrics|August 3, 2001
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy childrenB R Luce, K M Zangwill, C S Palmer, et al.
The New England Journal of Medicine|May 15, 1998
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in childrenR B Belshe, P M Mendelman, J Treanor, et al.
Vaccine|April 1, 1997
Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIBP M Mendelman, L Feeley, S Bird, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Pageof 7